Sung Tae Oh

1.0k total citations
54 papers, 800 citations indexed

About

Sung Tae Oh is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Sung Tae Oh has authored 54 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 24 papers in Gastroenterology and 18 papers in Surgery. Recurrent topics in Sung Tae Oh's work include Gastric Cancer Management and Outcomes (38 papers), Gastrointestinal Tumor Research and Treatment (24 papers) and Metastasis and carcinoma case studies (20 papers). Sung Tae Oh is often cited by papers focused on Gastric Cancer Management and Outcomes (38 papers), Gastrointestinal Tumor Research and Treatment (24 papers) and Metastasis and carcinoma case studies (20 papers). Sung Tae Oh collaborates with scholars based in South Korea and United States. Sung Tae Oh's co-authors include Jeong Hwan Yook, Byung Sik Kim, Yoon‐Koo Kang, Min‐Hee Ryu, Kee Don Choi, Gin Hyug Lee, Hwoon‐Yong Jung, Tae Won Kim, Jae‐Lyun Lee and Beom Su Kim and has published in prestigious journals such as Journal of Clinical Oncology, Medicine and Gastrointestinal Endoscopy.

In The Last Decade

Sung Tae Oh

51 papers receiving 784 citations

Peers

Sung Tae Oh
Sung Tae Oh
Citations per year, relative to Sung Tae Oh Sung Tae Oh (= 1×) peers Kim Barbara Luley

Countries citing papers authored by Sung Tae Oh

Since Specialization
Citations

This map shows the geographic impact of Sung Tae Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung Tae Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung Tae Oh more than expected).

Fields of papers citing papers by Sung Tae Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung Tae Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung Tae Oh. The network helps show where Sung Tae Oh may publish in the future.

Co-authorship network of co-authors of Sung Tae Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Sung Tae Oh. A scholar is included among the top collaborators of Sung Tae Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung Tae Oh. Sung Tae Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gong, Eun Jeong, Do Hoon Kim, Ji Yong Ahn, et al.. (2016). Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma. Gastric Cancer. 20(S1). 84–91. 39 indexed citations
3.
Yoon, Shinkyo, Changhoon Yoo, Min‐Hee Ryu, et al.. (2015). Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer. Gastric Cancer. 20(1). 182–189. 6 indexed citations
4.
Kim, Beom Su, Young Soo Park, Jeong Hwan Yook, Sung Tae Oh, & Byung Sik Kim. (2015). Differing Clinical Courses and Prognoses in Patients With Gastric Neuroendocrine Tumors Based on the 2010-WHO Classification Scheme. Medicine. 94(44). e1748–e1748. 19 indexed citations
5.
Park, Ji Hyun, Min‐Hee Ryu, Hwa Jung Kim, et al.. (2015). Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer. Gastric Cancer. 19(1). 226–233. 32 indexed citations
6.
Lee, Seohyun, Ji Yong Ahn, Hwoon‐Yong Jung, et al.. (2013). Clinical outcomes of endoscopic and surgical management for postoperative upper gastrointestinal leakage. Surgical Endoscopy. 27(11). 4232–4240. 32 indexed citations
7.
Lee, In‐Seob, Young Soo Park, Kab Choong Kim, et al.. (2012). Multiple synchronous early gastric cancers: High-risk group and proper management. Surgical Oncology. 21(4). 269–273. 17 indexed citations
8.
Kim, Mi Young, Young Soo Park, Kee Don Choi, et al.. (2011). Predictors of Recurrence After Resection of Small Gastric Gastrointestinal Stromal Tumors of 5 cm or Less. Journal of Clinical Gastroenterology. 46(2). 130–137. 21 indexed citations
9.
Choi, Kwi-Sook, Hwoon‐Yong Jung, Kee Don Choi, et al.. (2011). EMR versus gastrectomy for intramucosal gastric cancer: comparison of long-term outcomes. Gastrointestinal Endoscopy. 73(5). 942–948. 113 indexed citations
10.
Kang, Yoon‐Koo, Min‐Hee Ryu, Changhoon Yoo, et al.. (2010). Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 67(6). 1435–1443. 23 indexed citations
11.
Chung, Jun‐Won, Hwoon‐Yong Jung, Kee Don Choi, et al.. (2010). Extended indication of endoscopic resection for mucosal early gastric cancer: Analysis of a single center experience. Journal of Gastroenterology and Hepatology. 26(5). 884–887. 49 indexed citations
12.
Kim, Beom Su, Sung Tae Oh, Jeong Hwan Yook, et al.. (2010). Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses. The American Journal of Surgery. 200(3). 328–333. 26 indexed citations
13.
Sym, Sun Jin, Heung Moon Chang, Min‐Hee Ryu, et al.. (2009). Neoadjuvant Docetaxel, Capecitabine and Cisplatin (DXP) in Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer. Annals of Surgical Oncology. 17(4). 1024–1032. 47 indexed citations
14.
Sym, Sun Jin, Min‐Hee Ryu, Hye Jin Kang, et al.. (2009). Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 66(2). 373–380. 12 indexed citations
15.
Chang, Heung Moon, Min‐Hee Ryu, Se Jin Jang, et al.. (2008). <i>PDGFR</i>α Gene Mutation and Protein Expression in Gastrointestinal Stromal Tumors. Oncology. 74(1-2). 88–95. 8 indexed citations
16.
Kim, Dae Yeon, et al.. (2007). Correlation of the Body Mass Index with the Rates of Postoperative Wound Complications in Gastric Cancer Patients. Journal of the Korean Gastric Cancer Association. 7(4). 242–242. 1 indexed citations
17.
Kim, Hee Cheol, Jin Cheon Kim, Chang Sik Yu, et al.. (2005). Aberrant CpG island methylation in early-onset sporadic gastric carcinoma. Journal of Cancer Research and Clinical Oncology. 131(11). 733–740. 26 indexed citations
18.
Ryu, Je Ho, et al.. (2003). Clinicopathologic Characteristics and Prognostic Factors of Long-term Survivors of Borrmann Type 4 Gastric Cancer. Korean Journal of Gastroenterology. 41(1). 9–14. 2 indexed citations
19.
Kim, Wan Soo, et al.. (1997). Types of Postgastrctomy Efferent Loop Obstruction and its Management.. Journal of the Korean Surgical Society. 52(4). 543–551. 2 indexed citations
20.
Oh, Sung Tae, et al.. (1994). The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma: a multivariate analysis of prognostic factors. Journal of Korean Medical Science. 9(3). 248–248. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026